Clinical study on adefovir dipivoxil treatment on patients with chronic hepatitis B:65 case report
Zhai Peiren
Abstract
Zhai Peiren
Abstract
Objective To evaluate the efficacy of adefovir dipivoxil treatment on patients with chronic hepatitis B.Methods Adefovir dipivoxil and lamivudine were given to 39 patients with HBeAg-positive,and adefovir dipivoxil was given to 12 with HBeAg-positive and to 14 with HBeAg-negative hepatitis B,respectively for 24 weeks.Results Serum HBV DNA undetectable rates at 3 mon,6 mon,12 mon and 24 mon both in HBeAg-positive patients with adefovir dipivoxil and lamivudine or in HBeAg-negative patients with adefovir dipivoxil alone were higher than in HBeAg-positive patients with adefovir dipivoxil alone;the normalization of ALT in the three groups were not significantly different.Conclusion We recommend combination of adefovir dipivoxil and lamivudine therapy for patients HBeAg-positive hepatitis B.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the efficacy of adefovir dipivoxil treatment on patients with chronic hepatitis B.Methods Adefovir dipivoxil and lamivudine were given to 39 patients with HBeAg-positive,and adefovir dipivoxil was given to 12 with HBeAg-positive and to 14 with HBeAg-negative hepatitis B,respectively for 24 weeks.Results Serum HBV DNA undetectable rates at 3 mon,6 mon,12 mon and 24 mon both in HBeAg-positive patients with adefovir dipivoxil and lamivudine or in HBeAg-negative patients with adefovir dipivoxil alone were higher than in HBeAg-positive patients with adefovir dipivoxil alone;the normalization of ALT in the three groups were not significantly different.Conclusion We recommend combination of adefovir dipivoxil and lamivudine therapy for patients HBeAg-positive hepatitis B.
Key concepts: Adefovir, Lamivudine, Medicine, Chronic hepatitis, HBeAg, Gastroenterology, Internal medicine, Hepatitis B